SCHEDULE 13D/A Filed 2026-05-13 Event 2026-05-11 SEC 0001346824-26-000129 →

RA CAPITAL MANAGEMENT, L.P. → ARTIVA BIOTHERAPEUTICS, INC. ARTV

Stake: — Shares: 16,377,468 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

10 transactions

5 buys · 5 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

81 filings by this filer

80 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 5.13

1,921,843 shares short · +11.5% vs prior

Institutional Consensus · 2026-06-30

Held by elite portfolio managers

1 holder · $25.26M

Viking Global

Post-Filing Returns · since 2026-05-11 on ARTV

+1 day

+0.3%

+5 days

-13.0%

+30 days

-30.0%

+60 days

-9.1%

+90 days

—

+180 days

—

Anchor price 10.60 on closest trading day on/after 2026-05-11. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-07-13	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Buy	6,552	$8.94	$59K
2026-07-10	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Buy	15,102	$8.97	$135K
2026-06-11	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Buy	548,580	$7.91	$4.34M
2026-06-10	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Buy	103	$7.00	$721
2026-06-09	RA CAPITAL MANAGEMENT, L.P.	director, 10%+ owner	Buy	479,039	$6.91	$3.31M
2026-05-19	Raymon Heather	officer	Sale	3,095	$9.01	$28K
2026-05-19	Horan Christopher	officer	Sale	7,002	$9.01	$63K
2026-05-19	Bush Jennifer	officer	Sale	8,790	$9.01	$79K
2026-05-19	Banerjee Subhashis	officer	Sale	7,037	$9.01	$63K
2026-05-19	Aslan Fred	director, officer	Sale	27,116	$9.01	$244K

Other 13D/G Filings on ARTIVA BIOTHERAPEUTICS, INC.

Filed	Form	Filer	Stake	Shares
2026-07-23	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	—	18,415,956	view →
2026-06-15	SCHEDULE 13D/A	RA CAPITAL MANAGEMENT, L.P.	36.60%	17,811,623	view →
2026-05-28	SCHEDULE 13D/A	GC Corp.	12.30%	5,999,703	view →
2026-05-18	SCHEDULE 13G	VIKING GLOBAL INVESTORS LP	—	—	view →

Other Filings by RA CAPITAL MANAGEMENT, L.P.

Filed	Form	Issuer	Stake	Shares
2026-08-14	SCHEDULE 13D/A	SEPTERNA, INC.	—	5,525,324	view →
2026-08-11	SCHEDULE 13D/A	Wave Life Sciences, Inc.	—	34,314,406	view →
2026-08-10	SCHEDULE 13D/A	SAB Biotherapeutics, Inc.	—	9,609,852	view →
2026-07-23	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC.	—	18,415,956	view →
2026-07-22	SCHEDULE 13D/A	Freenome, Inc.	—	15,367,270	view →
2026-07-21	SCHEDULE 13D/A	VOR BIOPHARMA INC.	—	12,937,855	view →
2026-07-20	SCHEDULE 13G	Agenus Inc.	—	—	view →
2026-07-07	SCHEDULE 13D/A	Climb Bio, Inc. CLYM	33.00%	23,249,186	view →
2026-07-02	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	4.10%	1,985,541	view →
2026-06-26	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	6.00%	2,915,742	view →
2026-06-24	SCHEDULE 13D/A	SOLID BIOSCIENCES INC. SLDB	—	12,036,126	view →
2026-06-22	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	3,654,307	view →
2026-06-18	SCHEDULE 13D	Parabilis Medicines, Inc. PBLS	23.80%	28,933,371	view →
2026-06-15	SCHEDULE 13D/A	ARTIVA BIOTHERAPEUTICS, INC. ARTV	36.60%	17,811,623	view →
2026-06-15	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	5,138,703	view →
2026-06-03	SCHEDULE 13G	Editas Medicine, Inc. EDIT	—	—	view →
2026-05-21	SCHEDULE 13G	Sana Biotechnology, Inc. SANA	—	—	view →
2026-05-14	SCHEDULE 13D/A	WEREWOLF THERAPEUTICS, INC. HOWL	—	6,116,140	view →
2026-01-09	SCHEDULE	Cidara Therapeutics, Inc.	—	—	view →
2025-11-07	SCHEDULE	Sionna Therapeutics, Inc. SION	22.60%	10,071,712	view →

Showing 20 of 80

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →